Bristol-Myers Squibb Company (BRM.F)
Develops and sells medications for cancer, blood disorders, autoimmune diseases, and heart conditions
55.66-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+46.8%
The outlook
Bristol-Myers Squibb is trading near its 52-week highs, well above both its 50- and 200-day moving averages. The stock carries a trailing P/E of 17.7 and shows strong upward momentum in its price trend. Analyst coverage leans bullish overall based on current market positioning.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$113.66B
52-wk high
56.34
52-wk low
36.65
50-day avg
50.16
200-day avg
47.88
Trailing P/E
17.7